July 16, 2012 www.nomorefakenews.com
Health authorities have ordered the killing of hundreds of thousands of domestic animals in Asia, claiming they are carrying a dangerous virus. What’s the message?
We could be seeing a ramp-up to the announcement of another phony human epidemic of flu. This one would be a re-run of bird flu.
No doubt, because governments have stockpiled the flu drug, Tamiflu, they will advise people to take it. As with any business, when unsold supplies of product are sitting on the shelves, managers are told to move it to the public.
That’s why the devastating editorial that ran in the New York Times on April 10, 2012 (“Drug Data Shouldn’t Be Secret”) didn’t cause an agonizing reappraisal among governments around the world.
Authors Peter Doshi and Tom Jefferson reported on their investigation into Tamiflu, and concluded, “…the country’s most widely used and heavily stockpiled influenza drug appeared no more effective than aspirin.”
In the wake of a prior Doshi-Jefferson investigation, Tamiflu’s manufacturer, Roche, announced it would release a mountain of previously undisclosed data proving that Tamiflu was effective. More than two years later, Roche has not lived up to its promise. What is Roche hiding?
The US government, duped or complicit, holds a $1.5 billion stockpile of Tamiflu, in case the CDC and the World Health Organization (WHO) decide to promote another dud of an epidemic, like Swine Flu.
But, Doshi and Jefferson indicate, the FDA originally approved Tamiflu for treatment of the flu, based on the conclusion that “it could reduce the duration of flu symptoms by about a day.” So all the hammering hype about the need for Tamiflu was based on nearly NOTHING.
Furthermore, the FDA approval of the drug nowhere stated that Tamiflu could prevent person-to-person transmission of a flu bug.
Of course, this didn’t stop the CDC and WHO from acting as Tamiflu’s PR agents. These agencies made absurd claims that Tamiflu could shorten hospital stays for flu patients, could reduce serious flu complications, and could block transmissions of flu viruses.
As Doshi and Jefferson point out, these agencies had never read or even had access to the original clinical trial data on Tamiflu.
The story doesn’t end here. Doshi and Jefferson write: “More worrisome, we find suggestive evidence that Tamiflu interfered with the body’s ability to produce antibodies against influenza…”
In other words, Tamiflu, virtually ineffective, also reduces the body’s own natural immune response.
After the drug was released for public use, the following effects were observed: cardiac arrhythmia, seizures, bleeding colitis, detachment of the outer layer of the skin (life-threatening).
In 2006, the FDA changed Tamiflu’s warning label, adding delusion and hallucinations as potential effects.
In 2007, the Japanese government banned the use of Tamiflu by youngsters, aged 10-19, because the drug was found to induce hallucinations and self-harming behavior.
As Reuters reported on March 6, 2007 (“Tamiflu side effect concerns grow after Japan deaths”): “According to the [Japanese] Health Ministry, 54 people have died after taking Tamiflu, and in February a 14-year-old girl and boy fell to their deaths from their apartment homes in separate incidents, after taking the drug. Neither had left a suicide note.”
To sum up: the drug is virtually ineffective; the CDC and WHO claimed it was very effective, based on nothing; the drug’s manufacturer promised to present extensive data proving the drug is extremely effective; so far, the data have not be produced; the drug is quite dangerous.
If and when a new “epidemic” is promoted, will Tamiflu be recommended as the drug of choice? Will governments make every effort to move billions of dollars of unused stockpiled product off the shelves?
Is a snake-oil salesman a snake-oil salesman?
The author of an explosive new collection, THE MATRIX REVEALED, Jon was a candidate for a US Congressional seat in the 29th District of California. Nominated for a Pulitzer Prize, he has worked as an investigative reporter for 30 years, writing articles on politics, medicine, and health for CBS Healthwatch, LA Weekly, Spin Magazine, Stern, and other newspapers and magazines in the US and Europe. Jon has delivered lectures and seminars on global politics, health, logic, and creative power to audiences around the world.